Cargando…

Overcoming drug resistance in glioblastoma: new options in sight?

Detalles Bibliográficos
Autores principales:	Kopecka, Joanna, Riganti, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019268/ https://www.ncbi.nlm.nih.gov/pubmed/35582029 http://dx.doi.org/10.20517/cdr.2021.03

Ejemplares similares

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
por: Godel, Martina, et al.
Publicado: (2021)

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
por: Salaroglio, Iris Chiara, et al.
Publicado: (2018)

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer
por: Riganti, Chiara, et al.
Publicado: (2019)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
por: Kopecka, Joanna, et al.
Publicado: (2015)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

New Sight: Enzymes as Targets for Drug Development
por: Kim, Sung-Kun
Publicado: (2023)

Mitochondria-Targeted Drug Delivery
por: Kopecka, Joanna
Publicado: (2022)

Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
por: Campani, Virginia, et al.
Publicado: (2022)

ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
por: Salaroglio, Iris C., et al.
Publicado: (2019)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy
por: Corsetto, Paola Antonia, et al.
Publicado: (2017)

Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
por: Salaroglio, Iris C., et al.
Publicado: (2018)

Changes in sight
por: Talhari, Sinésio, et al.
Publicado: (2016)

Failing Sight
Publicado: (1880)

MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor
por: Riganti, Chiara, et al.
Publicado: (2020)

Ghostwriting Revisited: New Perspectives but Few Solutions in Sight
Publicado: (2011)

We shall overcome (drug resistance) some day
por: Sharma, Geeta G., et al.
Publicado: (2019)

Special Issue: “New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104)”
por: Vasconcelos, M. Helena, et al.
Publicado: (2022)

In sight but out of mind
por: The Lancet Planetary Health
Publicado: (2020)

Is the end of the pandemic really in sight?
por: Potvin, Louise
Publicado: (2021)

Targeting DNA repair pathways to overcome cancer drug resistance
por: van Waardenburg, Robert C.A.M., et al.
Publicado: (2021)

Commentary: New sight, lost sight, insight, and novel sight
por: Harken, Alden H.
Publicado: (2021)

An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
por: Campia, Ivana, et al.
Publicado: (2015)

PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy
por: Salaroglio, Iris C., et al.
Publicado: (2017)

Setting sights and giving thanks
por: The Lancet Rheumatology
Publicado: (2020)

Magnetic Healers and Sight Diagnosticians
Publicado: (1894)

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020)

Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors
por: Kopecka, Joanna, et al.
Publicado: (2016)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
por: Roux, Cecilia, et al.
Publicado: (2021)

Meiosis: no end in sight
por: Tong, Ming-Han
Publicado: (2021)

Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
por: Riganti, Chiara, et al.
Publicado: (2013)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models
por: Niso, Mauro, et al.
Publicado: (2021)

P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors
por: Kopecka, Joanna, et al.
Publicado: (2016)

Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death
por: Kopecka, Joanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_496r61e00tc1nenhpo62viukcf